BSE Live
Oct 21, 14:55Prev. Close
3147.45
Open Price
3153.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 21, 14:57Prev. Close
3147.30
Open Price
3147.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
3136.30 (11)
Profit & Loss account of Dr Lal PathLabs (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 1,330.20 | 1,203.36 | 1,056.89 | 912.30 | 791.32 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 1,330.20 | 1,203.36 | 1,056.89 | 912.30 | 791.32 | |
Total Operating Revenues | 1,330.40 | 1,203.42 | 1,056.92 | 912.38 | 791.32 | |
Other Income | 55.00 | 45.95 | 31.22 | 27.54 | 5.03 | |
Total Revenue | 1,385.40 | 1,249.37 | 1,088.14 | 939.92 | 796.35 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Operating And Direct Expenses | 298.70 | 262.35 | 226.03 | 197.08 | 172.92 | |
Changes In Inventories Of FGWIP And Stock In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Employee Benefit Expenses | 242.60 | 208.29 | 180.75 | 152.01 | 136.83 | |
Finance Costs | 15.30 | 0.84 | 0.84 | 0.70 | -14.25 | |
Depreciation And Amortisation Expenses | 72.80 | 38.22 | 33.06 | 27.54 | 28.28 | |
Other Expenses | 445.50 | 439.12 | 386.15 | 325.78 | 271.84 | |
Total Expenses | 1,074.90 | 948.82 | 826.82 | 703.10 | 595.63 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 310.50 | 300.55 | 261.32 | 236.82 | 200.72 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Profit/Loss Before Tax | 310.50 | 300.55 | 261.32 | 236.82 | 200.72 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 83.80 | 103.58 | 92.97 | 82.04 | 62.83 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | -0.90 | -3.50 | -3.40 | -0.81 | 4.11 | |
Other Direct Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 82.90 | 100.08 | 89.56 | 81.24 | 67.49 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 227.60 | 200.47 | 171.75 | 155.59 | 133.23 | |
Profit/Loss From Continuing Operations | 227.60 | 200.47 | 171.75 | 155.59 | 133.23 | |
Profit/Loss For The Period | 227.60 | 200.47 | 171.75 | 155.59 | 133.23 | |
Minority Interest | -1.70 | -1.29 | -1.02 | -1.00 | -1.04 | |
Consolidated Profit/Loss After MI And Associates | 225.90 | 199.18 | 170.73 | 154.59 | 132.19 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 27.00 | 24.00 | 21.00 | 19.00 | 16.00 | |
Diluted EPS (Rs.) | 27.00 | 24.00 | 21.00 | 19.00 | 16.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 127.70 | 54.70 | 31.60 | 36.82 | 20.27 | |
Tax On Dividend | 26.60 | 0.00 | 0.00 | 14.84 | 4.30 |
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
22.07.2025
23.06.2025
Dr Lal PathLabs, Metropolis, others fall up to 2% as Amazon launches home diagnostics services
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
25.04.2025
Dr Lal PathLab Standalone March 2025 Net Sales at Rs 577.20 crore, up 20.5% Y-o-Y
25.04.2025
Dr Lal PathLab Consolidated March 2025 Net Sales at Rs 602.60 crore, up 10.49% Y-o-Y
06.10.2021
Dr. Lal PathLabs Q2 PAT seen up 28.4% YoY to Rs 112 cr: Prabhudas Lilladher
18.01.2021
Dr. Lal PathLabs Q3 PAT seen up 27.4% YoY to Rs. 54.1 cr: Prabhudas Lilladher
11.10.2019
Dr Lal Pathlabs Q2 PAT seen up 48.8% YoY to Rs. 84.8 cr: Kotak
15.07.2019
Dr Lal Pathlabs Q1 PAT seen up 17.6% YoY to Rs. 58.1 cr: Kotak